CANG
Cango Inc.
There isn't enough reported data to score CANG yet.
NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
CANG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
CANG's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CANG PE Valuation
CANG has no meaningful PE right now: it lost money over the past year.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
CANG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Strongly improving | |
| Limited | |
| Moderate |
CANG has the edge over NKE on the outlook, with more favorable earnings expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CANG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $0.97 | +$1.09 |
| Q4 2023 | -$0.12 | +$2.93 |
| Q4 2022 | -$3.05 | -$3.02 |
| Q3 2022 | -$1.17 | -133% |
| Q2 2022 | -$1.89 | -121% |
| Q1 2022 | $0.30 | -96% |
| Q4 2021 | -$0.03 | -100% |
| Q3 2021 | $3.54 | -26% |
NKE has the stronger earnings trend. Trailing diluted EPS is down 49% for CANG versus NKE up 7.2%.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
CANG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $404.1M | +235% |
| Q4 2024 | $120.7M | -53% |
| Q4 2023 | $255.4M | +249% |
| Q4 2022 | $73.1M | -54% |
| Q3 2022 | $62.5M | -48% |
| Q2 2022 | $43.4M | -69% |
| Q1 2022 | $118.2M | -30% |
| Q4 2021 | $157.7M | -4.3% |
CANG has the stronger quarterly revenue trend. Revenue is up 453% for CANG versus down 4.3% for NKE.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -58% | -14 points |
| Q2 2025 | -72% | -26 points |
| Q4 2024 | 22% | +145 points |
| Q4 2023 | -4.3% | +20 points |
| Q4 2022 | -43% | -29 points |
| Q3 2022 | -46% | -41 points |
| Q2 2022 | -122% | -124 points |
| Q1 2022 | -24% | -38 points |
CANG's operating margin was −58% last quarter, down 14 points from the same quarter a year ago, near the bottom of its range since 2016.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
CANG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$46.6M | -130% |
| Q4 2023 | $153.7M | +$153.7M |
| Q4 2022 | $0 | $0 |
| Q3 2022 | $0 | $0 |
| Q2 2022 | $0 | $0 |
| Q1 2022 | $0 | $0 |
| Q4 2021 | $0 | $0 |
| Q3 2021 | $0 | $0 |
CANG has the stronger cash trend. Its trailing FCF is up 365% versus its history, compared with NKE at down 52%.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
CANG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.5% | -4.4M shares |
| 1 year | -23% | -12.4M shares |
| 3 years | -30% | -17.9M shares |
| 5 years | -17% | -8.4M shares |
| Available history | -17% | -8.4M shares |
CANG has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $13.6M |
| Q4 2023 | $37M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CANG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -4.4x | Net Cash |
| Q4 2021 | 3.1x | Elevated |
| Q3 2021 | 4.0x | Elevated |
| Q2 2021 | 2.3x | Moderate |
| Q1 2021 | 1.5x | Healthy |
| Q4 2020 | 3.4x | Elevated |
| Q3 2020 | 4.0x | High |
| Q2 2020 | 0.8x | Very low |
CANG has more cash than debt.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
CANG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.8 | Neutral |
| Stochastic | 9.7 | Oversold |
CANG's weekly RSI is 40 (neutral) and its Stochastic is 10 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CANG PE vs Consumer Cyclical Sector
| Metric | CANG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CANG has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
CANG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.09 | 24% below |
| 20 week MA | $2.03 | 22% below |
| 50 week MA | $5.48 | 71% below |
| 100 week MA | $13.7 | 88% below |
| 200 week MA | $10.7 | 85% below |
CANG is in a downtrend: it's below all five of its weekly moving averages, and 85% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over CANG on trend strength, trading above more of its moving averages.
CANG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.0 | $36.3 | -16% |
| 2021 | $36.3 | $16.1 | -56% |
| 2022 | $16.1 | $6.70 | -58% |
| 2023 | $6.70 | $5.10 | -24% |
| 2024 | $5.10 | $24.6 | +382% |
| 2025 | $24.6 | $13.9 | -43% |
| 2026 YTD | $13.9 | $1.59 | -89% |
CANG's yearly returns have swung widely, from +382% in 2024 to −58% in 2022. It's down 89% so far in 2026.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over CANG on returns for 2026, with the stronger performance.